Teva Canada Proclaims the Launch of (Pr)Teva-Pantoprazole Magnesium, a generic of (Pr)Tecta®


TORONTO, Nov. 17, 2015 /CNW/ – Teva Canada Restricted, a subsidiary of Teva Pharmaceutical Industries Ltd., introduced that Well being Canada has accredited its utility for the generic model of PrTecta®. This treatment is indicated for the therapy of circumstances the place a discount of gastric acid secretion is required, together with duodenal ulcer, gastric ulcer, reflux esophagitis and symptomatic gastro-esophageal reflux illness (corresponding to acid regurgitation and heartburn).

PrTecta® had annual gross sales of roughly $138.8 million in Canada, primarily based on IMS Brogan gross sales knowledge as of September 2015. PrTeva-Pantoprazole Magnesium is on the market instantly in pharmacies throughout Canada.

“Proton pump inhibitor drugs are used to deal with a variety of important circumstances affecting thousands and thousands of Canadians,” mentioned Doug Sommerville, Senior Vice President and Normal Supervisor, Teva Canada Restricted. “We’re very happy to have the ability to provide our extra reasonably priced, bioequivalent model of Tecta to sufferers in the present day. By utilizing decrease value generic prescription medicines, our authorities, employers and customers saved almost $14.8 billion in 2014 alone. It’s our ongoing dedication to play a vital position in making certain the sustainability of the healthcare system.”

In response to the Canadian Digestive Well being Basis, greater than 1.3 million Canadians live with abdomen ulcers, and since 2006 the variety of Canadians with ulcers has elevated 1.5 occasions. One in each ten Canadians will develop a abdomen ulcer in some unspecified time in the future of their lifetime.i

About Teva Canada Restricted

Teva Canada Restricted, headquartered in Toronto, has supplied reasonably priced healthcare options for 50 years, with almost 200,000ii prescriptions full of our merchandise day-after-day. Initially Novopharm Restricted, Teva Canada specializes within the growth, manufacturing and advertising of high-quality generic prescription prescribed drugs and thru our branded division, Teva Canada Innovation, focuses on a various line of modern merchandise in quite a lot of therapeutic areas. Teva Canada employs greater than 1,300 people, markets greater than 400iii merchandise in Canada and is a subsidiary of Teva Pharmaceutical Industries Ltd., the world’s largest generic drug maker. For extra data, go to: or

About Teva Pharmaceutical Industries Ltd.

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) is a number one world pharmaceutical firm that delivers high-quality, patient-centric healthcare options to thousands and thousands of sufferers day-after-day. Headquartered in Israel, Teva is the world’s largest generic medicines producer, leveraging its portfolio of greater than 1,000 molecules to provide a variety of generic merchandise in almost each therapeutic space. In specialty medicines, Teva has a world-leading place in modern remedies for problems of the central nervous system, together with ache, in addition to a robust portfolio of respiratory merchandise. Teva integrates its generics and specialty capabilities in its world analysis and growth division to create new methods of addressing unmet affected person wants by combining drug growth capabilities with gadgets, companies and applied sciences. Teva’s web revenues in 2014 amounted to $20.3 billion. For extra data, go to

Canadian Digestive Well being Basis. Statistics. Accessed October 2015.
ii IMS Compuscript TRx MAT September 2015
iii IMS CD&H MAT September 2015

SOURCE Teva Canada Restricted

For additional data: PR Contact: Teva Pharmaceutical Industries Ltd., Denise Bradley, Sr. Vice President, International Company Popularity, Teva Prescription drugs, p. +1.215.591.8974, [email protected]


Supply hyperlink